« BE - AstraZeneca v. Teva / AstraZeneca v. Sandoz | Main | EPO - First request by the Administrative Council that the EBA proposes the removal of a member of the BoA from office held inadmissible »

25/11/2015

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Categories

EPLAW Patent Blog sponsors:

Enter your email address:

Delivered by FeedBurner